CN Patent

CN108017626A — 一种坎格列净半水合物新晶型

Assigned to Shanghai Aobo Bio Pharmaceutical Technology Co Ltd · Expires 2018-05-11 · 8y expired

What this patent protects

本发明涉及一种坎格列净(1‑(β‑D‑吡喃葡糖基)‑4‑甲基‑3‑[5‑(4‑氟苯基)‑2‑噻吩基甲基]苯)半水合物的新晶型，所述的坎格列净半水合物新晶型使用Cu‑Kα辐射检测的X射线粉末衍射图谱中在约3.8，7.7，11.6，15.5，19.4，23.3，27.3，31.3(±0.2)度有特征峰。

USPTO Abstract

本发明涉及一种坎格列净(1‑(β‑D‑吡喃葡糖基)‑4‑甲基‑3‑[5‑(4‑氟苯基)‑2‑噻吩基甲基]苯)半水合物的新晶型，所述的坎格列净半水合物新晶型使用Cu‑Kα辐射检测的X射线粉末衍射图谱中在约3.8，7.7，11.6，15.5，19.4，23.3，27.3，31.3(±0.2)度有特征峰。

Drugs covered by this patent

Patent Metadata

Patent number
CN108017626A
Jurisdiction
CN
Classification
—
Expires
2018-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Aobo Bio Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.